NO309965B1 - Oralt farmasøytisk antihostepreparat - Google Patents
Oralt farmasøytisk antihostepreparat Download PDFInfo
- Publication number
- NO309965B1 NO309965B1 NO963634A NO963634A NO309965B1 NO 309965 B1 NO309965 B1 NO 309965B1 NO 963634 A NO963634 A NO 963634A NO 963634 A NO963634 A NO 963634A NO 309965 B1 NO309965 B1 NO 309965B1
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutically acceptable
- benzydamine
- dextromethorphan
- preparation according
- antitussive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI940362A IT1274026B (it) | 1994-03-01 | 1994-03-01 | Composizione antitosse |
| PCT/EP1995/000658 WO1995023602A1 (en) | 1994-03-01 | 1995-02-22 | Antitussive composition containing an antitussive and benzydamine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO963634D0 NO963634D0 (no) | 1996-08-30 |
| NO963634L NO963634L (no) | 1996-08-30 |
| NO309965B1 true NO309965B1 (no) | 2001-04-30 |
Family
ID=11368015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963634A NO309965B1 (no) | 1994-03-01 | 1996-08-30 | Oralt farmasøytisk antihostepreparat |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5932589A (it) |
| EP (1) | EP0748222B1 (it) |
| JP (1) | JP3348858B2 (it) |
| KR (1) | KR970701047A (it) |
| CN (1) | CN1088358C (it) |
| AT (1) | ATE195074T1 (it) |
| AU (1) | AU681257B2 (it) |
| BR (1) | BR9506956A (it) |
| CA (1) | CA2184594C (it) |
| CZ (1) | CZ284798B6 (it) |
| DE (1) | DE69518229T2 (it) |
| DK (1) | DK0748222T3 (it) |
| ES (1) | ES2149969T3 (it) |
| FI (1) | FI963394L (it) |
| GR (1) | GR3034665T3 (it) |
| HU (1) | HUT75937A (it) |
| IT (1) | IT1274026B (it) |
| NO (1) | NO309965B1 (it) |
| NZ (1) | NZ281230A (it) |
| PL (1) | PL178608B1 (it) |
| PT (1) | PT748222E (it) |
| RO (1) | RO117147B1 (it) |
| RU (1) | RU2143901C1 (it) |
| SK (1) | SK282567B6 (it) |
| UA (1) | UA37278C2 (it) |
| WO (1) | WO1995023602A1 (it) |
| ZA (1) | ZA951588B (it) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124282A (en) * | 1997-05-22 | 2000-09-26 | Sellers; Edward M. | Drug formulations |
| JP2001526228A (ja) * | 1997-12-22 | 2001-12-18 | ユーロ−セルティーク,エス.エイ. | オピオイド作動薬/拮抗薬の併用 |
| EP1181010A4 (en) * | 1999-04-06 | 2003-03-26 | Wrigley W M Jun Co | PHARMACEUTICAL CHEWING GUM FORMULATIONS |
| US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
| AU2003219348A1 (en) * | 2002-04-22 | 2003-11-03 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| US9757461B2 (en) * | 2005-01-14 | 2017-09-12 | Camurus Ab | GnRH analogue formulations |
| CN101219140B (zh) * | 2007-12-24 | 2011-06-01 | 重庆市莱美药物技术有限公司 | 盐酸苄达明可溶片及其制备方法 |
| SG176686A1 (en) | 2009-07-08 | 2012-01-30 | Acraf | USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES |
| KR102290178B1 (ko) * | 2013-03-13 | 2021-08-18 | 트리스 파마 인코포레이티드 | 벤조나테이트 변형 방출 고체 정제 및 캡슐 |
| JP6698669B2 (ja) * | 2015-02-09 | 2020-05-27 | セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited | 粘膜炎の治療のための組成物及び方法 |
| WO2018191477A1 (en) * | 2017-04-14 | 2018-10-18 | Kempharm, Inc. | Dextrorphan prodrugs and processes for making and using them |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054833A (it) * | 1963-08-09 | |||
| US5196436A (en) * | 1990-10-31 | 1993-03-23 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
| CA2129676C (en) * | 1990-10-31 | 1997-09-30 | Ronald Lee Smith | Dextromethorphan antitussive compositions |
-
1994
- 1994-03-01 IT ITMI940362A patent/IT1274026B/it active IP Right Grant
-
1995
- 1995-02-22 FI FI963394A patent/FI963394L/fi not_active Application Discontinuation
- 1995-02-22 JP JP52267395A patent/JP3348858B2/ja not_active Expired - Fee Related
- 1995-02-22 RO RO96-01736A patent/RO117147B1/ro unknown
- 1995-02-22 AT AT95909772T patent/ATE195074T1/de not_active IP Right Cessation
- 1995-02-22 SK SK1085-96A patent/SK282567B6/sk unknown
- 1995-02-22 AU AU18116/95A patent/AU681257B2/en not_active Ceased
- 1995-02-22 EP EP95909772A patent/EP0748222B1/en not_active Expired - Lifetime
- 1995-02-22 DK DK95909772T patent/DK0748222T3/da active
- 1995-02-22 US US08/700,362 patent/US5932589A/en not_active Expired - Fee Related
- 1995-02-22 ES ES95909772T patent/ES2149969T3/es not_active Expired - Lifetime
- 1995-02-22 WO PCT/EP1995/000658 patent/WO1995023602A1/en not_active Ceased
- 1995-02-22 HU HU9602390A patent/HUT75937A/hu unknown
- 1995-02-22 NZ NZ281230A patent/NZ281230A/en not_active IP Right Cessation
- 1995-02-22 PL PL95316079A patent/PL178608B1/pl not_active IP Right Cessation
- 1995-02-22 DE DE69518229T patent/DE69518229T2/de not_active Expired - Fee Related
- 1995-02-22 UA UA96093730A patent/UA37278C2/uk unknown
- 1995-02-22 CZ CZ962532A patent/CZ284798B6/cs not_active IP Right Cessation
- 1995-02-22 KR KR1019960704800A patent/KR970701047A/ko not_active Ceased
- 1995-02-22 CN CN95191917A patent/CN1088358C/zh not_active Expired - Fee Related
- 1995-02-22 RU RU96120415A patent/RU2143901C1/ru not_active IP Right Cessation
- 1995-02-22 CA CA002184594A patent/CA2184594C/en not_active Expired - Fee Related
- 1995-02-22 PT PT95909772T patent/PT748222E/pt unknown
- 1995-02-22 BR BR9506956A patent/BR9506956A/pt not_active IP Right Cessation
- 1995-02-24 ZA ZA951588A patent/ZA951588B/xx unknown
-
1996
- 1996-08-30 NO NO963634A patent/NO309965B1/no not_active IP Right Cessation
-
2000
- 2000-10-23 GR GR20000402355T patent/GR3034665T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60022021T2 (de) | Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion | |
| DE69610323T2 (de) | Sich schnell im munde auflösende zusammensetzungen für dopaminagonisten | |
| US6248789B1 (en) | Administration of ketamine to manage pain and to reduce drug dependency | |
| DE60009346T2 (de) | Buprenorphin enthaltende analgetische zusammensetzungen | |
| DE60026146T2 (de) | Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion | |
| JP2009073842A (ja) | 苦痛を管理しおよび薬物依存性を軽減するための、ケタミンの投与 | |
| MXPA96003633A (en) | Use of ketamine and device for the nasal and eye administration of ketamine for the management of pain and for detoxification | |
| JPH10505864A (ja) | 種々の頑固な疾患の治療のための医薬の製造に有用な組成物 | |
| JP2021080276A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
| EP1154795B1 (en) | Means for treating and diagnosing restless legs syndrome | |
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| NO309965B1 (no) | Oralt farmasøytisk antihostepreparat | |
| JPH01246221A (ja) | フエノール含有鎮咳液体組成物 | |
| US5414005A (en) | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation | |
| KR20090125748A (ko) | 대상포진 후 신경통 치료용 정제 및 대상포진 후 신경통의 치료 방법 | |
| JPH05201861A (ja) | デキストロメトルフアンの鎮咳効果の増強 | |
| JPS61293929A (ja) | ド−パミン作働薬を包含する製薬組成物 | |
| JP2001526217A (ja) | 血管性頭痛に対する局所麻酔薬の新規な使用 | |
| JP2000095707A (ja) | 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物 | |
| JPH06502428A (ja) | デキストロメトルファン鎮咳組成物 | |
| JPH0518811B2 (it) | ||
| JP2001089375A (ja) | 感冒用組成物 | |
| MXPA96003747A (en) | Antitus composition | |
| WO1997000072A1 (en) | Anti-inflammatory/analgetic composition | |
| JPH09136843A (ja) | 血圧上昇薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |